首页|亮丙瑞林联合孕激素治疗子宫内膜增生不伴非典型性患者的效果

亮丙瑞林联合孕激素治疗子宫内膜增生不伴非典型性患者的效果

扫码查看
目的:观察亮丙瑞林联合孕激素治疗子宫内膜增生不伴非典型性(EH)患者的效果.方法:选取2021年1月至2023年1月该院收治的 86 例EH患者进行前瞻性研究,按随机数字表法将其分为对照组与研究组各 43 例.对照组采用醋酸甲羟孕酮片治疗,研究组在对照组基础上联合注射用醋酸亮丙瑞林微球治疗,比较两组治疗前后性激素[促黄体生成素(LH)、促卵泡生成素(FSH)、雌二醇(E2)]水平、子宫内膜厚度、月经期,临床疗效,以及不良反应发生率.结果:治疗后,两组LH、FSH、E2 水平均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05);治疗后,两组子宫内膜厚度均小于治疗前,且研究组小于对照组,两组月经期均短于治疗前,且研究组短于对照组,差异有统计学意义(P<0.05);研究组治疗总有效率为 97.67%(42/43),高于对照组的 69.77%(30/43),差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:亮丙瑞林联合孕激素治疗EH患者可提高治疗总有效率,缩小子宫内膜厚度,缩短月经期,降低性激素水平,其效果优于单纯孕激素治疗.
Effects of Leuprorelin combined with Progesterone in treatment of endometrial hyperplasia without atypia
Objective:To observe effects of Leuprorelin combined with Progesterone in treatment of endometrial hyperplasia without atypia(EH).Methods:A prospective study was conducted on 86 patients with EH admitted to the hospital from January 2021 to January 2023.According to the random number table method,they were divided into control group and study group,43 cases in each group.The control group was treated with Medroxyprogesterone acetate tablets,while the study group was treated with Leuprorelin acetate microspheres for injection on the basis of that of the control group.The levels of sex hormones[luteinizing hormone(LH),follicle stimulating hormone(FSH),estradiol(E2)],the endometrial thickness,the menstrual period,the clinical efficacy,and the incidence of adverse reactions were compared between the two groups before and after the treatment.Results:After the treatment,the levels of LH,FSH and E2 in the two groups were lower than those before the treatment,those in the study group were lower than those in the control group,and the differences were statistically significant(P<0.05).After the treatment,the endometrial thickness levels of the two groups were smaller than those before the treatment,and that in the study group was smaller than that in the control group;the menstrual period levels of the two groups were shorter than those before the treatment,and that in the study group was shorter than that in the control group;and the differences were statistically significant(P<0.05).The total effective rate of treatment in the study group was 97.67%(42/43),which was higher than 69.77%(30/43)in the control group,and the difference was statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Leuprorelin combined with high-dose Progesterone in the treatment of the EH patients can improve the total effective rate of treatment,reduce the endometrial thickness,shorten the menstrual period and reduce the sex hormone levels.Moreover,it is superior to single Progesterone therapy.

LeuprorelinProgesteroneEndometrial hyperplasia without atypiaSex hormoneEndometriumMenstrual period

康黎芳

展开 >

泰和县妇幼保健计划生育服务中心妇产科,江西 吉安 343700

亮丙瑞林 孕激素 子宫内膜增生不伴非典型性 性激素 子宫内膜 月经期

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(8)
  • 10